617 related articles for article (PubMed ID: 28549791)
1. MicroRNAs in gynecological cancers: Small molecules with big implications.
Srivastava SK; Ahmad A; Zubair H; Miree O; Singh S; Rocconi RP; Scalici J; Singh AP
Cancer Lett; 2017 Oct; 407():123-138. PubMed ID: 28549791
[TBL] [Abstract][Full Text] [Related]
2. Role of microRNAs in gynecological pathology.
Gilabert-Estelles J; Braza-Boils A; Ramon LA; Zorio E; Medina P; Espana F; Estelles A
Curr Med Chem; 2012; 19(15):2406-13. PubMed ID: 22455593
[TBL] [Abstract][Full Text] [Related]
3. Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview.
Di Fiore R; Suleiman S; Pentimalli F; O'Toole SA; O'Leary JJ; Ward MP; Conlon NT; Sabol M; Ozretić P; Erson-Bensan AE; Reed N; Giordano A; Herrington CS; Calleja-Agius J
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917022
[TBL] [Abstract][Full Text] [Related]
4. Non-coding RNAs related to angiogenesis in gynecological cancer.
Rahimian N; Razavi ZS; Aslanbeigi F; Mirkhabbaz AM; Piroozmand H; Shahrzad MK; Hamblin MR; Mirzaei H
Gynecol Oncol; 2021 Jun; 161(3):896-912. PubMed ID: 33781555
[TBL] [Abstract][Full Text] [Related]
5. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
[TBL] [Abstract][Full Text] [Related]
6. Role of microRNAs in regulating cell proliferation, metastasis and chemoresistance and their applications as cancer biomarkers in small cell lung cancer.
Pandey M; Mukhopadhyay A; Sharawat SK; Kumar S
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188552. PubMed ID: 33892053
[TBL] [Abstract][Full Text] [Related]
7. microRNAs as biomarkers of ovarian cancer.
Zhang H; Lu B
Expert Rev Anticancer Ther; 2020 May; 20(5):373-385. PubMed ID: 32326768
[No Abstract] [Full Text] [Related]
8. The microRNA Let-7 and its exosomal form: Epigenetic regulators of gynecological cancers.
Wang F; Zhou C; Zhu Y; Keshavarzi M
Cell Biol Toxicol; 2024 Jun; 40(1):42. PubMed ID: 38836981
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-21 in gynecological cancers: From molecular pathogenesis to clinical significance.
Jiang NJ; Yin YN; Lin J; Li WY; Long DR; Mei L
Pathol Res Pract; 2023 Aug; 248():154630. PubMed ID: 37393665
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA and gynecologic cancers.
Kanekura K; Nishi H; Isaka K; Kuroda M
J Obstet Gynaecol Res; 2016 Jun; 42(6):612-7. PubMed ID: 27098274
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer.
Lu Y; Govindan R; Wang L; Liu PY; Goodgame B; Wen W; Sezhiyan A; Pfeifer J; Li YF; Hua X; Wang Y; Yang P; You M
Carcinogenesis; 2012 May; 33(5):1046-54. PubMed ID: 22331473
[TBL] [Abstract][Full Text] [Related]
12. The Role of microRNAs in Epithelial Ovarian Cancer Metastasis.
Nguyen VHL; Yue C; Du KY; Salem M; O'Brien J; Peng C
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993038
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression.
Ahadi A
IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236
[TBL] [Abstract][Full Text] [Related]
14. Interplay between LncRNA/miRNA and TGF-β Signaling in the Tumorigenesis of Gynecological Cancer.
Safavi P; Moghadam KB; Haghighi Z; Ferns GA; Rahmani F
Curr Pharm Des; 2024; 30(5):352-361. PubMed ID: 38303530
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs as Modulators of Oral Tumorigenesis-A Focused Review.
Rishabh K; Khadilkar S; Kumar A; Kalra I; Kumar AP; Kunnumakkara AB
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33806361
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs, an active and versatile group in cancers.
Liu J; Zheng M; Tang YL; Liang XH; Yang Q
Int J Oral Sci; 2011 Oct; 3(4):165-75. PubMed ID: 22010574
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D and VDR in Gynecological Cancers-A Systematic Review.
Deuster E; Jeschke U; Ye Y; Mahner S; Czogalla B
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29113037
[TBL] [Abstract][Full Text] [Related]
18. Role of microRNAs in endocrine cancer metastasis.
Lima CR; Gomes CC; Santos MF
Mol Cell Endocrinol; 2017 Nov; 456():62-75. PubMed ID: 28322989
[TBL] [Abstract][Full Text] [Related]
19. Extracellular urinary microRNAs as non-invasive biomarkers of endometrial and ovarian cancer.
Hanžek A; Siatka C; Duc AE
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7981-7993. PubMed ID: 36914786
[TBL] [Abstract][Full Text] [Related]
20. Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers.
Hashemipour M; Boroumand H; Mollazadeh S; Tajiknia V; Nourollahzadeh Z; Rohani Borj M; Pourghadamyari H; Rahimian N; Hamblin MR; Mirzaei H
Gynecol Oncol; 2021 Apr; 161(1):314-327. PubMed ID: 33581845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
